Sally-Ann Cryan
School of Pharmacy and Biomolecular Sciences
Royal College of Surgeons in Ireland (RCSI)
Sally-Ann Cryan has not added Biography.
If you are Sally-Ann Cryan and would like to personalize this page please email our Author Liaison for assistance.
Carrier-based strategies for targeting protein and peptide drugs to the lungs.
The AAPS journal Mar, 2005 | Pubmed ID: 16146340
Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.
Molecular pharmaceutics Mar-Apr, 2006 | Pubmed ID: 16579639
The development of a tissue-engineered tracheobronchial epithelial model using a bilayered collagen-hyaluronate scaffold.
Biomaterials Apr, 2016 | Pubmed ID: 26871888
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery.
Advanced drug delivery reviews 07, 2016 | Pubmed ID: 27151307
Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.
Materials (Basel, Switzerland) Jan, 2018 | Pubmed ID: 29342838
Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Jan, 2019 | Pubmed ID: 30385419
Knockdown of Gene Expression in Macrophages by microRNA Mimic-Containing Poly (Lactic--glycolic Acid) Microparticles.
Medicines (Basel, Switzerland) Dec, 2018 | Pubmed ID: 30558310
Transfection of autologous host cells in vivo using gene activated collagen scaffolds incorporating star-polypeptides.
Journal of controlled release : official journal of the Controlled Release Society 06, 2019 | Pubmed ID: 31075346
Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.
Drug delivery and translational research 04, 2020 | Pubmed ID: 31691161
Corrigendum to "Transfection of autologous host cells in vivo using gene activated collagen scaffolds incorporating star-polypeptides" [J. Control. Release 304(2019) 191-203].
Journal of controlled release : official journal of the Controlled Release Society 04, 2020 | Pubmed ID: 31986312
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Seónadh O’Leary1,
Ahmad Z. Bahlool1,2,
Gemma O’Connor2,
Sally-Ann Cryan2,3,4,
Joseph M. Keane1,
Mary P. O’Sullivan1
1Department of Clinical Medicine, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, The University of Dublin,
2School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI),
3SFI Advanced Materials and Bioengineering Research (AMBER) Centre, RCSI & TCD,
4SFI Centre for Research in Medical Devices (CURAM), RCSI, Dublin and National University of Ireland
